Lupin

Solving The Challenges And Setting The Trend With The 3rd Annual Cleaning Validation 2023: A Practical Approach

New Delhi, September 19, 2023: Eminence Business Media's third edition of the Cleaning Validation program, which took place at Radisson…

1 year ago

Global Pharmaceutical Quality Summit Amplifies Conversations on Making Quality Pharmaceuticals in India, Sustainably, for the World

Day 2 of IPA's Pharmaceutical Quality Summit brought together global leaders and regulators across industries, emphasizing the importance of a…

3 years ago

Indian Pharmaceutical Alliance (IPA) organises 7th Global Pharmaceutical Quality Summit to share best practices in Sustainable Operations and Quality Excellence

The IPA's Pharmaceutical Quality Summit goes global, with leaders from around the world discussing best practices New Delhi, February 25,…

3 years ago

Lupin launches Sciflix a mobile-friendly learning platform for post graduate students specializing in pulmonology

Mumbai, December 02, 2021: Global pharma major Lupin Limited (Lupin) announced today the launch of Sciflix, an educational mobile adaptable…

3 years ago

TB Alliance and Lupin Announce Commercial Partnership for New Therapy for Highly Drug-Resistant TB

Mumbai, September 06, 2021: Non-profit drug developer, TB Alliance has granted global pharma major Lupin Limited (Lupin), a non-exclusive license…

3 years ago

Bidencare boost for desi pharma companies

Mumbai, November 11, 2020: The Indian pharma sector is expected to benefit from the Biden presidency on the back of…

4 years ago

Lupin Launches Atorvastatin Calcium Tablets USP

National, September 29, 2020: Pharma major Lupin Limited (Lupin) announced the launch of Atorvastatin Calcium Tablets USP, 10 mg, 20…

4 years ago

Lupin Presents Phase 3 Data for SolosecĀ® (secnidazole) Demonstrating Significant Response Rate in Female Patients with Trichomoniasis

Results presented at the 2020 Infectious Diseases Society for Obstetrics & Gynecology (IDSOG) Virtual Annual Meeting Single-dose treatment with SolosecĀ®…

4 years ago

Lupin Launches Zileuton Extended-Release Tablets

Mumbai, August 11, 2020: Pharma major Lupin Limited (Lupin) announced the launch of Zileuton Extended-Release Tablets, 600 mg, having received…

4 years ago

Lupin’s Alliance Partner Concord Receives U.S. FDA Approval for Mycophenolate Mofetil Tablets USP

New Delhi, August 07, 2020: Pharma major Lupin Limited (Lupin) in alliance with Concord Biotech Limited (Concord) announced that it…

4 years ago